What are the evidence‑based strategies to prevent pressure ulcers in hospitalized patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Prevention of Decubitus Ulcers in Hospitalized Patients

All hospitalized patients at risk for pressure ulcers should receive advanced static mattresses or advanced static overlays as the primary prevention strategy, combined with systematic risk assessment, routine repositioning, nutritional optimization, and skin care. 1

Risk Assessment

Perform a structured risk assessment on admission to identify high-risk patients 1. While the evidence supporting specific risk assessment tools is weak, this practice allows you to target preventive interventions appropriately. Patients with limited mobility, older age, cognitive impairment, incontinence, diabetes, malnutrition, or hypoalbuminemia require heightened vigilance 1.

Reassess risk regularly during hospitalization—patients who receive ongoing reassessment have lower rates of hospital-acquired pressure ulcers 2.

Support Surfaces: The Cornerstone of Prevention

Use advanced static mattresses or advanced static overlays for all at-risk patients 1. This is a strong recommendation based on moderate-quality evidence and represents the most robust preventive intervention available.

Avoid alternating-air mattresses or alternating-air overlays—the ACP guideline specifically recommends against these devices despite their widespread marketing 1. The evidence shows they are not superior to advanced static surfaces and may be less effective.

Apply specialized foam overlays on operating tables for surgical patients, as this reduces intraoperative pressure ulcer development 3.

Repositioning and Mobility

Reposition patients routinely, though the optimal frequency remains unclear from the evidence 3. The key caveat: repositioning alone without other interventions is insufficient 4. Repositioning becomes more effective when:

  • Supported by pressure-mapping technology feedback
  • Integrated into a comprehensive prevention bundle
  • Combined with appropriate support surfaces

Patients who receive routine repositioning as documented in their care plan have lower pressure ulcer rates 2.

Skin Assessment and Care

Conduct a comprehensive skin assessment on admission and reassess regularly 2. Patients receiving documented skin assessments have significantly lower rates of hospital-acquired pressure ulcers.

Apply moisturizers to maintain skin integrity, particularly over the sacrum 3. While the incremental benefit of specialized topical agents over simple moisturizers is unclear, maintaining skin hydration is an appropriate preventive strategy.

Nutritional Support

Optimize nutritional status and consider dietary supplements for malnourished patients 1, 3. Nutritional support may be beneficial, though the evidence is not as strong as for support surfaces. Address hypoalbuminemia and provide adequate protein and caloric intake.

Moisture Management

Implement aggressive moisture management protocols for incontinent patients 5. Moisture management is performed consistently (>91%) in successful prevention programs and represents a modifiable risk factor.

Prophylactic Dressings

Consider applying prophylactic dressings to high-risk bony prominences (sacrum, trochanters, heels) 4. Single-intervention studies show these can be effective when used alongside other preventive measures—not in isolation.

Implementation Strategy: The Bundle Approach

The evidence strongly favors multicomponent prevention programs over single interventions 4, 6. Effective programs integrate:

  • Standardized protocols with simplified documentation
  • Multidisciplinary team involvement with designated "skin champions"
  • Ongoing staff education about prevention strategies
  • Sustained audit and feedback systems to monitor compliance
  • Electronic reminders in the inpatient care plan 4

Studies implementing these bundled approaches show moderate-strength evidence for reducing pressure ulcer rates from baseline levels of 7.9% among at-risk patients 2.

Critical Pitfalls to Avoid

Do not rely solely on risk assessment tools for prevention—they identify at-risk patients but don't prevent ulcers by themselves 4. Action must follow assessment.

Do not use repositioning or support surfaces in isolation—single interventions are less effective than comprehensive programs 4.

Do not assume alternating-air surfaces are superior—despite marketing claims, the evidence recommends against them 1.

Do not neglect ongoing reassessment—initial assessment alone is insufficient; continuous monitoring is essential 2.

Related Questions

What are the recommended care and preventive skin‑care measures for pressure ulcers (decubitus ulcers) ranging from Grade I to Grade IV?
What are the National Database of Nursing Quality Indicators (NDNQI) benchmarks for hospital-acquired pressure injury (HAPI) prevalence and incidence?
How should an infected pressure ulcer in an adult be managed, including antimicrobial therapy, surgical debridement, and pressure off‑loading?
What is the management for a 58-year-old patient with a 9% total body surface area (TBSA) burn, four days post‑injury?
What is the appropriate management for a pressure ulcer (bed sore) on the coccyx (tailbone)?
Given a uric acid level of 6 mg/dL, a C‑reactive protein of 1 mg/L, and a rheumatoid factor of 21.6 IU/mL, what is the likely significance and recommended next evaluation?
How is an injury to the tibionavicular ligament managed in an adult without significant comorbidities?
Should piperacillin‑tazobactam be stopped and how long should vancomycin be continued in a patient with L4‑L5 discitis caused by Staphylococcus aureus susceptible to vancomycin who has been receiving both antibiotics for five days?
What does a positive hepatitis A antibody with a negative IgM result indicate about infection status and need for treatment?
What is the recommended dosing regimen of Yaz (drospirenone/ethinyl estradiol) for acne treatment?
For a patient with Staphylococcus aureus causing L4‑L5 discitis, which antibiotic—clindamycin (MIC 0.25 µg/mL) or linezolid (MIC 2 µg/mL)—would be the preferred choice?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.